Bioscience

Receive News & Ratings for Meridian Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Meridian Bioscience and related companies with MarketBeat.

Finally, Millennium Management LLC raised its holdings in shares of Daré Bioscience by 73.9% during the 2nd quarter.

HC Wainwright raised their price target on shares of Daré Bioscience from $6.00 to $7.00 and gave the stock a “buy” rating in a research note on Tuesday, December 13th.

In addition, the company owns various synergistic businesses under Gage Growth, Pinnacle, TerrAscend NJ, Ilera Healthcare, HMS Health and HMS Processing, Valhalla Confections, State Flower, Arise Bioscience Inc., and TerrAscend Canada brands.

Jenny Whilde is an Adjunct Research Scientist in Marine Bioscience at the University of Florida.

New Mexico scientists have formed nearly 150 bioscience startups in just the past 10 years.

On average, equities analysts forecast that Harvard Bioscience, Inc. will post 0.12 earnings per share for the current year.

Sell-side analysts predict that Aadi Bioscience, Inc. will post -2.53 EPS for the current year.

That compares to run-rate unit sales of Narcan of under 3 million to Emergent Bioscience.

The South Bay Workforce Investment Board (SBWIB) conducted a graduation ceremony on Dec. 12 for 28 Morningside High School seniors who have recently participated in the SBWIB’s Bioscience Pre-Apprenticeship Program.

Vanguard Group Inc. raised its stake in Harvard Bioscience by 12.8% in the 1st quarter.

We are currently developing the platform for North American distribution around our rights to use Lexaria Bioscience Corp.’s ground-breaking DehydraTECH patent portfolio for product development, licensing and B2B sales of cannabis ingredients.

What’s more, birth controlis perceived to address a health condition “that is not life-threatening,” notes Sabrina Martucci Johnson, CEO of Daré Bioscience, a women’s health company developing a nonhormonal contraceptive for Bayer.

Justin is a member of Biopharma Leaders of Color (BLOC) and Bioscience & Investor Inclusion Group (BIIG).

Nonetheless, the No Virus/Terrain Theory camp continues to demand impossible isolation studies from the Germ Theory proponents rather than just say conventional bioscience is bunk.

On Wednesday, October 2nd, Paula Green sold 3,310 shares of Twist Bioscience stock.

Sir Tony added there was a unique "opportunity in Britain with the NHS because it's a single payer system, and you have got data that is of immense value to creating your bioscience industry into and to letting it flourish".

Tidal Investments LLC decreased its position in shares of Twist Bioscience Co. () by 60.0% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission.

Twist Bioscience Co. ( sold 798 shares of the business’s stock in a transaction dated Friday, May 3rd.

Twist Bioscience had a negative return on equity of 32.16% and a negative net margin of 78.44%.